Restatement of Previously Issued Financial Statements (Tables)

9 Months Ended

Jun. 30, 2025

Restatement of Previously Issued Financial Statements [Abstract]

Schedule of Restatements - Unaudited Condensed Consolidated Statements of Operations and Comprehensive loss

Summary of Restatements – Unaudited Condensed Consolidated Statements of Operations and Comprehensive loss:

		For the Three Months Ended June 30, 2024
		As previously reported				Adjustments				Reference		As restated

Operating expenses:
General and administrative expenses		$	2,132,149			$	(119,211	)		a, c, e		$	2,012,938
Total operating expenses			2,132,149				(119,211	)		a, c, e			2,012,938

Loss from operations			(2,132,149	)			119,211			a, c, e			(2,012,938	)

Other income (expenses)
Interest expense, net			(5,796	)			514			e			(5,282	)
Other expenses, net			—				(311	)		c			(311	)
Total other expense, net			(5,796	)			203			c, e			(5,593	)

Loss before income taxes			(2,137,945	)			119,414			a, c, e			(2,018,531	)

Income tax expense			—				—						—

Net loss		$	(2,137,945	)		$	119,414			a, c, e		$	(2,018,531	)

Foreign currency translation adjustment			(18,415	)			(1,937	)		a, c, e			(20,352	)

Total comprehensive loss attributable to ordinary shareholders		$	(2,156,360	)		$	117,477			a, c, e		$	(2,038,883	)

Weighted average number of ordinary shares outstanding - basic and diluted*			2,445,688				(41	)		d			2,445,647

Loss per ordinary share - basic and diluted*		$	(0.87	)		$	0.04			a, b, c, d e		$	(0.83	)

*	Giving retroactive effect to reverse recapitalization effected on March 14, 2024 to reflect exchange ratio of approximately 55.1 as described in Note 4 and share combination at a ratio of one-for-sixty effected on August 25, 2025 as described in Note 1.

Summary of Restatements - Unaudited Condensed Consolidated Statements of Operations and Comprehensive loss:

		For the Nine Months Ended June 30, 2024
		As previously reported				Adjustments				Reference		As restated

Operating expenses:
General and administrative expenses		$	14,139,078			$	2,189,882			a, b, c, e		$	16,328,960
Total operating expenses			14,139,078				2,189,882			a, b, c, e			16,328,960

Loss from operations			(14,139,078	)			(2,189,882	)		a, b, c, e			(16,328,960	)

Other income (expenses)
Interest expense, net			(17,440	)			(345,044	)		a, c			(362,484	)
Other expenses, net			—				(1,363	)		c			(1,363	)
Total other expense, net			(17,440	)			(346,407	)		a, c			(363,847	)

Loss before income taxes			(14,156,518	)			(2,536,289	)		a, b, c, e			(16,692,807	)

Income tax expense			—				—						—

Net loss		$	(14,156,518	)		$	(2,536,289	)		a, b, c, e		$	(16,692,807	)

Foreign currency translation adjustment			(29,994	)			(164,327	)		a, b, c, e			(194,321	)

Total comprehensive loss attributable to ordinary shareholders		$	(14,186,512	)		$	(2,700,616	)		a, b, c, e		$	(16,887,128	)

Weighted average number of ordinary shares outstanding - basic and diluted*			972,814				1,382,286			d			2,355,100

Loss per ordinary share - basic and diluted*		$	(14.55	)		$	7.46			a, b, c, d, e		$	(7.09	)

*	Giving retroactive effect to reverse recapitalization effected on March 14, 2024 to reflect exchange ratio of approximately 55.1 as described in Note 4 and share combination at a ratio of one-for-sixty effected on August 25, 2025 as described in Note 1.

Schedule of Restatements - Unaudited Condensed Consolidated Statements of Cash Flows

Summary of Restatements - Unaudited Condensed Consolidated Statements of Cash Flows:

		For the Nine Months Ended June 30, 2024
		As previously reported				Adjustments				Reference		As restated

Cash flows from operating activities:
Net loss		$	(14,156,518	)		$	(2,536,289	)		a, b, e		$	(16,692,807	)
Adjustments to reconcile net loss to net cash used in operating activities.
Amortization expense			323,772				(323,696	)		a, e			76
Depreciation expense			3,870				(12	)		e			3,858
Foreign currency translation			(29,994	)			29,994			e			—
Changes in operating assets and liabilities
Prepaid expenses			125,596				(32,110	)		d, e			93,486
Advance to a related company			97,882				(529	)		e			97,353
Deposits			(43,114	)			(763	)		e			(43,877	)
Other receivables			(47,018	)			(337	)		e			(47,355	)
Interests payable			17,433				(9	)		e			17,424
Other payables			(289,900	)			290,000			d			100
Accrued expenses			(878,520	)			1,071,791			d, e			193,271
Related party payable			(88,542	)			88,542			d			—
Deferred underwriting fee			(2,000,000	)			2,000,000			d			—
Payable to directors			2,463,297				(2,463,297	)		a, c, d, e			—
Provision for bonus			10,154,677				3,645,323			c			13,800,000
Net cash used in operating activities			(4,347,079	)			1,768,608			a, b, c, d, e			(2,578,471	)

Cash flows from investing activities:
Purchases of property and equipment			(1,271,043	)			(691	)		e			(1,271,734	)
Net cash used in investing activities			(1,271,043	)			(691	)		e			(1,271,734	)

Cash flows from financing activities:
Proceeds from issuance of shares			6,260,259				(6,260,259	)		d			—
Repayment of working capital loan			(555,358	)			555,358			d			—
Proceeds from long-term debt - related party			—				2,583,996			c			2,583,996
Repayments to long-term debt - related party			—				(105,988	)		c			(105,988	)
Payments of deferred merger costs			—				(919,446	)		b, e			(919,446	)
Proceeds from the completion of reverse recapitalization			—				1,231			d			1,231
Proceeds from PIPE investment			—				2,500,000			b, c, d, e			2,500,000
Net cash provided by financing activities			5,704,901				(1,645,108	)		b, c, d, e			4,059,793

Effect of exchange rate changes			—				(122,809	)		e			(122,809	)

Net change in cash			86,779				—						86,779

Cash - beginning of the period			1,430				—						1,430

Cash - end of the period		$	88,209			$	—					$	88,209